scispace - formally typeset
R

Richard S. Johannes

Researcher at Brigham and Women's Hospital

Publications -  55
Citations -  3705

Richard S. Johannes is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Framingham Risk Score & Mortality rate. The author has an hindex of 29, co-authored 55 publications receiving 3221 citations. Previous affiliations of Richard S. Johannes include University of California, Los Angeles & Becton Dickinson.

Papers
More filters
Journal ArticleDOI

The early prediction of mortality in acute pancreatitis: a large population-based study

TL;DR: The BISAP is a simple and accurate method for the early identification of patients at increased risk for in-hospital mortality in acute pancreatitis.
Journal ArticleDOI

A longitudinal survey of self-reported bowel habits in the United States

TL;DR: Female gender, black race, fewer years of education, low physical activity, and symptoms of depression were independent risk factors for impaired bowel function.
Journal ArticleDOI

A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding

TL;DR: AIMS65 is a simple, accurate risk score that predicts in-hospital mortality, LOS, and cost in patients with acute upper GI bleeding and is validated by using data routinely available at initial evaluation.
Journal ArticleDOI

Pancreatic stent placement for duct disruption

TL;DR: A bridging stent is associated with a successful outcome after pancreatic duct stent placement for duct disruption, and only the bridgingStent position remained correlated to outcome.
Journal ArticleDOI

A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis.

TL;DR: The BISAP score represents a simple way to identify patients at risk of increased mortality and the development of intermediate markers of severity within 24 h of presentation and can be utilized to improve clinical care and facilitate enrollment in clinical trials.